Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
13.00
+1.07 (8.97%)
Jun 30, 2026, 12:08 PM EDT - Market open

Eloxx Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.364.790.111.1319.2142.27
Cash & Short-Term Investments
6.364.790.111.1319.2142.27
Cash Growth
5632.43%4210.81%-90.21%-94.10%-54.56%71.35%
Accounts Receivable
--2.72---
Other Current Assets
2.140.490.150.410.921.21
Total Current Assets
8.55.272.981.5520.1343.48
Net Property, Plant & Equipment
---0.160.991.66
Total Assets
8.55.272.981.7121.1245.14
Accounts Payable
3.032.715.355.73.021.38
Accrued Expenses
1.241.6521.212.84.2
Current Portion of Long-Term Debt
-16.522.223.98-
Current Portion of Leases
--00.130.710.66
Unearned Revenue
11.8211.8213.3512.9712.543.72
Other Current Liabilities
--0.10.470.05-
Total Current Liabilities
16.0917.1827.3122.723.099.96
Long-Term Debt
---1.618.5612
Long-Term Leases
---00.140.8
Total Long-Term Liabilities
---1.618.6912.8
Total Liabilities
16.0917.1827.3124.3131.7822.76
Common Stock
0.050.050.040.030.020.02
Treasury Stock
------2.19
Additional Paid-in Capital
296.7288.63270.22268.81263.71262.88
Retained Earnings
-304.33-300.58-294.59-291.44-274.39-238.32
Shareholders' Equity
-7.58-11.91-24.34-22.6-10.6622.38
Total Liabilities & Equity
8.55.272.981.7121.1245.14